HEYTEA EDINBURGH LIMITED

Company number SC811557 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

HEYTEA EDINBURGH LIMITED - Analysis Report

Company Number: SC811557

Analysis Date: 2025-07-19 12:26 UTC

Financial Health Assessment for HEYTEA EDINBURGH LIMITED


1. Financial Health Score: D

Explanation:
As a newly incorporated company with dormant status, HEYTEA EDINBURGH LIMITED has very minimal financial activity and resources. The financial "vital signs" show almost no operational metrics to evaluate, reflecting an embryonic business stage. While not indicating distress, the dormant status and negligible assets suggest the company is in the incubation phase rather than a healthy operational state.


2. Key Vital Signs

Metric Value Interpretation
Company Age ~4 months Very young; limited operating history, early stage of business development
Account Category Dormant No significant trading or financial transactions during the period
Current Assets £1 Minimal liquidity; effectively no cash flow or working capital
Net Current Assets £1 Working capital positive but negligible; no operational buffer
Net Assets (Shareholders' Funds) £1 Essentially no equity capital beyond nominal share capital
Employee Count 0 No staff; no operational activity or payroll commitments
Director(s) 1 Single director actively appointed, indicating governance structure in place
Significant Control One firm (Dragon Fly Edinburgh Ltd) with >75% control Single controlling interest, potentially centralised decision-making
Filing Status Up to date Compliance with filing deadlines; no overdue filings or penalties
Industry SIC Code 56210 Event catering activities; a sector likely requiring operational investment and activity

3. Diagnosis

The company is in a dormant state, with only nominal financial figures reported for its initial period from incorporation to 30 September 2024. Dormant status implies the company has not conducted any trading activities or incurred expenses. This is typical for a startup or a newly formed entity that has yet to commence active operations.

The balance sheet shows only £1 in current assets and shareholders' funds, reflecting the minimum share capital and no business transactions. No liabilities or debts are recorded, which means there are no financial obligations or pressures at this stage.

The absence of employees and minimal financial data suggest the company is in the pre-operational phase, possibly preparing for future trading or awaiting investment or contracts.

There are no symptoms of financial distress—no debts, no losses—but equally, there are no positive signs of revenue generation or cash flow. This "healthy dormancy" is common in startups before market entry.


4. Recommendations

  • Commence Trading and Build Operations: To move from dormancy, the company should begin trading activities, generating revenue, and building operational capacity consistent with event catering.

  • Capital Injection: Consider increasing share capital or securing investment to provide working capital for initial expenses such as equipment, staff, premises, and marketing.

  • Cash Flow Management: Once trading begins, establish rigorous cash flow monitoring to avoid liquidity shortages, which can be fatal for startups.

  • Compliance Continuation: Maintain up-to-date filings to avoid penalties and to build credibility with stakeholders.

  • Strategic Planning: Develop a business plan outlining target markets, cost structure, pricing, and growth milestones to guide operations and attract investors.

  • Risk Assessment: As the company moves into active trading, implement risk controls for operational, financial, and market risks inherent in event catering.


Medical Analogy Summary

Think of HEYTEA EDINBURGH LIMITED as a newborn patient with vital signs stable but minimal activity—no fever, no cough, but also no heartbeat of commerce yet. It is in a dormant phase, akin to a patient resting before an operation. The prognosis depends on timely activation of trading functions and capital infusion to stimulate growth and avoid "financial atrophy."


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 19 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.